Delivery Order SPE2DR25D1034-SPE2DR26FPV8M
Award Date 11/13/25
Potential Completion Date 11/14/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,207.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.99 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 7, 2025, with completion scheduled for November 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a biologic immunosuppressant medication used to treat various inflammatory and autoimmune conditions,...
- The Defense Logistics Agency awarded a $2,387.94 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award selection. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.94 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. HUMIRA is a widely-used biologic medication for treating autoimmune conditions, and this order represents a...
- The Defense Logistics Agency awarded a $2,265.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside contract represents a pharmaceutical supply delivery under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.20 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on October 24, 2025, with completion scheduled for October 27, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of supply under AmerisourceBergen's larger pharmaceutical support framework with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable medication used to treat autoimmune conditions. This firm fixed-price delivery order, with completion scheduled for November 5, 2025, represents a direct purchase under a competitive procurement process with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,321.40 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat various inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,597.89 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 6, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a fulfillment under the company's larger pharmaceutical supply contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...